APA (7th ed.) Citation

Minohara, K., Matoba, T., Kawakita, D., Takano, G., Oguri, K., Murashima, A., . . . Iwasaki, S. (2021). Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab. Nature Portfolio.

Chicago Style (17th ed.) Citation

Minohara, Kiyoshi, et al. Novel Prognostic Score for Recurrent or Metastatic Head and Neck Cancer Patients Treated with Nivolumab. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Minohara, Kiyoshi, et al. Novel Prognostic Score for Recurrent or Metastatic Head and Neck Cancer Patients Treated with Nivolumab. Nature Portfolio, 2021.

Warning: These citations may not always be 100% accurate.